secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001104659-22-074300
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering shareholders elect two Class I directors and ratify auditor RSM US LLP
--------------------------------------------------------------------------------

- Ann E. Berman and Diana F. Hausman, M.D. elected as Class I directors with over 18M votes each.
- Ratification of RSM US LLP as auditor for FY2022 passed with 20,719,504 votes for, 30 against, 1,100 abstained.
- Quorum of 20,720,634 shares (78.5% of outstanding) present at June 21, 2022 Annual Meeting.
- No other proposals were voted on at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000110465922074300/0001104659-22-074300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000110465922074300/tm2219295d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-074300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer